Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6433-6447
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6433
Table 1 Examples of epigenetic alterations found in gastric cancer
Alteration sourceExpressionAlteration targetRef.
DNA hypermethylationDownSignal pathway mediator genes (ADAMTS9, BCL2L10, BCL6B, BNIP3, CXCL12, DAPK, DKK1, DKK3, DLL1, FBLN1, GATA4, HOXD10, LMX1A, OPCML, PCDH10, RELN, SFRP proteins, , SOX17, TIMP3, VEZT)[100-120]
DownChromatin-modifying enzyme genes (MGMT, SMARCA5)[93,140]
DownMicroRNA genes (Let-7f, MIR10B, MIR34C, MIR137, MIR155, MIR182, MIR195, MIR200B, MIR200C, MIR210, MIR212, MIR338, MIR375, MIR378, MIR429, MIR449)[127-139]
DNA hypomethylationUpALDH2, ASCL2, MTHFR, SULF1, SULF2, TERF2[122-126]
UpMicroRNA gene (MIR93)[83]
H3/H4 hyperacetylationUpMYC[107]
H3/H4 deacetylationDownGATA, RND3[149,150]
H3 dephosphorylationDownc-JUN, HSP70[151]
MicroRNA functionDownChromatin-modifying enzyme genes (DNMT1, DNMT3A, DNMT3B, UHRF1)[141,142]